shopping cart Your cart is empty
  • Home
  • Biotechnology
  • DNA Testing Market By Product Type (Instruments, Reagents), By Technology (PCR, Microarrays, Sequencing Technology, Mass Spectrome...

DNA Testing Market By Product Type (Instruments, Reagents), By Technology (PCR, Microarrays, Sequencing Technology, Mass Spectrometry),By Application (Oncology, Infectious Disease Testing, Clinical Diagnosis Confirmation, Prenatal Diagnosis), By End Users (Point Of Care, Central Laboratories), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: May 4, 2016

Key Findings


The global DNA testing market is expected to grow at the CAGR of 9.9% during 2015-2022. The major factors driving the market are increasing chronic and infectious diseases, growing point of care centers and technological advancement. With the growing infectious and chronic diseases the need for DNA testing is increasing rapidly resulting in growth of the market. Point of care centers are increasing, it provides DNA testing convenient from the patients residences and facilitates prompt result. Although the high cost involved in R&D acts as restrain to the market.


Market Segment Insight


The market is majorly segmented on the basis of product type, technology, application and end user. On the basis of product type it is further segmented by instruments, reagents and software services. The instrument segments hold the largest share due to rapidly growing healthcare sector. On the basis of technology the market is segmented by PCR, microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry. PCR contributed the largest market share due to high availability of products. On the basis of application the market is segmented by Oncology, Infectious disease testing, Myogenic disorder diagnosis. The infectious disease segment dominates the market, the growing infectious diseases, large number of products such as HBV, HCV, HIV, TB, CT/NG, HPV, and MRSA are available for testing infectious diseases. On the basis end user the market is segmented by point of care, central laboratories and self testing. Point of care testing is the fastest growing segment as it facilitates prompt result.


Regional Insight


Based on geography the market is segmented into North America, Europe, APAC and Row. North America has the largest market share globally and is followed by Europe, Asia pacific and Row. North America dominates the market due to increasing healthcare industry, supportive government regulations and increasing number of patient population with chronic disease. The revenue generated by the region in 2014 was $ 2600 million. Asia pacific is the fastest growing market it is expected to grow by 8% from 2014 to 2022 due to increasing R&D and growing infectious diseases.


Competitive Insights


The key players in the market are Novartis,Johnson and Johnson,Bio-Rad Laboratories,Thermo Fisher Scientific,Illumina, Inc.,Gen-probe Inc. (Hologic),Cephide Inc.,Abbott Laboratories,Roche Diagnostics,Bayer Diagnostic,Sysmex,Agilent Technologies Inc.,GE Healthcare,Transgenomic Inc,Qiagen.Product portfolio expansion, Acquisition, Mergers, Agreements are the key strategies adopted by the companies.

CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12


CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL DNA TESTING MARKETSUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL DNA TESTING MARKETOUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL DNA TESTING MARKETVALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13


CHAP 3. GLOBAL DNA TESTING MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. INCREASING INFECTIOUS AND CHRONIC DISEASES 14
3.1.2. GROWING POINT OF CARE CENTERS 14
3.1.3. TECHNOLOGICAL ADVANCEMENT 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. HUGE COST INVOLVED IN R&D 14
3.2.2. STRINGENT GOVERNMENT REGULATIONS 14
3.3. KEY OPPORTUNITIES 14
3.3.1. INCREASING HEALTH AWARENESS 14
3.3.2. RISISNG MARKET IN DEVELOPING COUNTRIES 14
3.4. CHALLENGES 14
3.4.1. UNCLEAR REIMBURSEMENT STRUCTURE 14


CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL DNA TESTING MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL DNA TESTING MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL DNA TESTING MARKET– GAP ANALYSIS 15


CHAP 5. GLOBAL DNA TESTING MARKETMARKET BY PRODUCT TYPE 2012-2022 ($ BILLION) 16
5.1. GLOBAL DNA TESTING MARKET BY INSTRUMENTS2012-2022 ($ BILLION) 16
5.2. GLOBAL DNA TESTING MARKET BY REAGENTS 2012-2022 ($ BILLION) 16


CHAP 6. GLOBAL DNA TESTING MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 17
6.1. GLOBAL DNA TESTING MARKET BY PCR 2012-2022 ($ BILLION) 17
6.2. GLOBAL DNA TESTING MARKET BY MICROARRAYS 2012-2022 ($ BILLION) 17
6.4. GLOBAL DNA TESTING MARKET BY SEQUENCING TECHNOLOGY 2012-2022 ($ BILLION) 17
6.5. GLOBAL DNA TESTING MARKET BY MASS SPECTROMETRY 2012-2022 ($ BILLION) 17


CHAP 7. GLOBAL DNA TESTING MARKET BY APPLICATION 2012-2022 ($ BILLION) 18
7.1. GLOBAL DNA TESTING MARKET BY ONCOLOGY 2012-2022 ($ BILLION) 18
7.1.1. PROSTATE CANCER 18
7.1.2. BREAST CANCER 18
7.1.3. COLORECTAL CANCER 18
7.1.4. OTHERS 18
7.2. GLOBAL DNA TESTING MARKET BY INFECTIOUS DISEASE TESTING 2012-2022 ($ BILLION) 18
7.2.1. HEPATITIS B VIRUS (HBV) 18
7.2.2. HEPATITIS C VIRUS (HCV) 18
7.2.3. HUMAN IMMUNODEFICIENCY VIRUS (HIV) 18
7.2.4. TUBERCULOSIS (TB) 18
7.2.5. CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) 18
7.2.6. HUMAN PAPILLOMAVIRUS (HPV) 18
7.2.7. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) 18
7.2.8. OTHERS 18
7.4. GLOBAL DNA TESTING MARKET BY CLINICAL DIAGNOSIS CONFIRMATION 2012-2022 ($ BILLION) 18
7.5. GLOBAL DNA TESTING MARKET BY PRENATAL DIAGNOSIS2012-2022 ($ BILLION) 18


CHAP 8. GLOBAL DNA TESTING MARKET BY END USERS 2012-2022 ($ BILLION) 19
8.1. GLOBAL DNA TESTING MARKET BY POINT OF CARE 2012-2022 ($ BILLION) 19
8.2. GLOBAL DNA TESTING MARKET BY CENTRAL LABORATORIES 2012-2022 ($ BILLION) 19


CHAP 9. GLOBAL DNA TESTING MARKET, REGIONAL OUTLOOK 2012-2022($ BILLION) 20
9.1. GLOBAL DNA TESTING MARKETBY REGION 2012-2022 ($ BILLION) 20
9.2. NORTH AMERICA 20
9.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
9.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.2.3.1. U.S. 20
9.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.2.3.2. CANADA 20
9.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.3. EUROPE 20
9.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
9.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.3.3.1. GERMANY 20
9.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
9.3.3.2. UK 21
9.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
9.3.3.3. FRANCE 21
9.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
9.3.3.4. REST OF EUROPE 21
9.3.3.4.1. OTHERS MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 21
9.3.3.4.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 21
9.4. ASIA PACIFIC 21
9.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 21
9.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
9.4.3.1. CHINA 21
9.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
9.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
9.4.3.2. INDIA 22
9.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
9.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
9.4.3.3. JAPAN 22
9.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
9.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 22
9.4.3.4. OTHERS 22
9.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 22
9.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 22
9.5. REST OF THE WORLD 22
9.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
9.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22


CHAP 10. COMPETITIVE LANDSCAPE 23
10.1. NOVARTIS 23
10.1.1. COMPANY OVERVIEW 23
10.1.2. SCOT ANALYSIS 23
10.1.3. PRODUCT BENCHMARKING 23
10.1.4. STRATEGIC INITIATIVES 23
10.2. JOHNSON AND JOHNSON 23
10.2.1. COMPANY OVERVIEW 23
10.2.2. SCOT ANALYSIS 23
10.2.3. PRODUCT BENCHMARKING 23
10.2.4. STRATEGIC INITIATIVES 23
10.3. BIO-RAD LABORATORIES 23
10.3.1. COMPANY OVERVIEW 23
10.3.2. SCOT ANALYSIS 23
10.3.3. PRODUCT BENCHMARKING 23
10.3.4. STRATEGIC INITIATIVES 23
10.4. THERMO FISHER SCIENTIFIC 23
10.4.1. COMPANY OVERVIEW 23
10.4.2. SCOT ANALYSIS 23
10.4.3. PRODUCT BENCHMARKING 23
10.4.4. STRATEGIC INITIATIVES 23
10.5. ILLUMINA, INC. 23
10.5.1. COMPANY OVERVIEW 23
10.5.2. SCOT ANALYSIS 23
10.5.3. PRODUCT BENCHMARKING 23
10.5.4. STRATEGIC INITIATIVES 23
10.6. GEN-PROBE INC. (HOLOGIC) 24
10.6.1. COMPANY OVERVIEW 24
10.6.2. SCOT ANALYSIS 24
10.6.3. PRODUCT BENCHMARKING 24
10.6.4. STRATEGIC INITIATIVES 24
10.7. CEPHIDE INC. 24
10.7.1. COMPANY OVERVIEW 24
10.7.2. SCOT ANALYSIS 24
10.7.3. PRODUCT BENCHMARKING 24
10.7.4. STRATEGIC INITIATIVES 24
10.8. ABBOTT LABORATORIES 24
10.8.1. COMPANY OVERVIEW 24
10.8.2. SCOT ANALYSIS 24
10.8.3. PRODUCT BENCHMARKING 24
10.8.4. STRATEGIC INITIATIVES 24
10.9. ROCHE DIAGNOSTICS 25
10.9.1. COMPANY OVERVIEW 25
10.9.2. SCOT ANALYSIS 25
10.9.3. PRODUCT BENCHMARKING 25
10.9.4. STRATEGIC INITIATIVES 25
10.10. BAYER DIAGNOSTIC 25
10.10.1. COMPANY OVERVIEW 25
10.10.2. SCOT ANALYSIS 25
10.10.3. PRODUCT BENCHMARKING 25
10.10.4. STRATEGIC INITIATIVES 25
10.11. SYSMEX 25
10.11.1. COMPANY OVERVIEW 25
10.11.2. SCOT ANALYSIS 25
10.11.3. PRODUCT BENCHMARKING 25
10.11.4. STRATEGIC INITIATIVES 25
10.12. AGILENT TECHNOLOGIES INC. 25
10.12.1. COMPANY OVERVIEW 25
10.12.2. SCOT ANALYSIS 25
10.12.3. PRODUCT BENCHMARKING 25
10.12.4. STRATEGIC INITIATIVES 25
10.13. GE HEALTHCARE, 25
10.13.1. COMPANY OVERVIEW 25
10.13.2. SCOT ANALYSIS 25
10.13.3. PRODUCT BENCHMARKING 25
10.13.4. STRATEGIC INITIATIVES 25
10.14. TRANSGENOMIC INC 25
10.14.1. COMPANY OVERVIEW 25
10.14.2. SCOT ANALYSIS 25
10.14.3. PRODUCT BENCHMARKING 26
10.14.4. STRATEGIC INITIATIVES 26
10.15. QIAGEN 26
10.15.1. COMPANY OVERVIEW 26
10.15.2. SCOT ANALYSIS 26
10.15.3. PRODUCT BENCHMARKING 26
10.15.4. STRATEGIC INITIATIVES 26

TABLE 1 GLOBAL DNA TESTING MARKETMARKET BY PRODUCT TYPE 2012-2022 ($ BILLION) 26
TABLE 2 GLOBAL DNA TESTING MARKET BY INSTRUMENTS2012-2022 ($ BILLION) 26
TABLE 3 GLOBAL DNA TESTING MARKET BY REAGENTS 2012-2022 ($ BILLION) 26
TABLE 4 GLOBAL DNA TESTING MARKET BY SOFTWARE AND SERVICE 2012-2022 ($ BILLION) 26
TABLE 5 GLOBAL DNA TESTING MARKET BY OTHERS 2012-2022 ($ BILLION) 26
TABLE 6 GLOBAL DNA TESTING MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 27
TABLE 7 GLOBAL DNA TESTING MARKET BY PCR 2012-2022 ($ BILLION) 27
TABLE 8 GLOBAL DNA TESTING MARKET BY MICROARRAYS 2012-2022 ($ BILLION) 27
TABLE 9 GLOBAL DNA TESTING MARKET BY IN SITU HYBRIDIZATION 2012-2022 ($ BILLION) 27
TABLE 10 GLOBAL DNA TESTING MARKET BY SEQUENCING TECHNOLOGY 2012-2022 ($ BILLION) 27
TABLE 11 GLOBAL DNA TESTING MARKET BY MASS SPECTROMETRY 2012-2022 ($ BILLION) 27
TABLE 12 GLOBAL DNA TESTING MARKET BY OTHERS 2012-2022 ($ BILLION) 27
TABLE 13 GLOBAL DNA TESTING MARKET BY APPLICATION 2012-2022 ($ BILLION) 27
TABLE 14 GLOBAL DNA TESTING MARKET BY ONCOLOGY 2012-2022 ($ BILLION) 27
TABLE 15 PROSTATE CANCER 27
TABLE 16 BREAST CANCER 27
TABLE 17 COLORECTAL CANCER 27
TABLE 18 OTHERS 27
TABLE 19 GLOBAL DNA TESTING MARKET BY INFECTIOUS DISEASE TESTING 2012-2022 ($ BILLION) 27
TABLE 20 HEPATITIS B VIRUS (HBV) 27
TABLE 21 HEPATITIS C VIRUS (HCV) 27
TABLE 22 HUMAN IMMUNODEFICIENCY VIRUS (HIV) 27
TABLE 23 TUBERCULOSIS (TB) 27
TABLE 24 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) 27
TABLE 25 HUMAN PAPILLOMAVIRUS (HPV) 27
TABLE 26 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) 27
TABLE 27 OTHERS 27
TABLE 28 GLOBAL DNA TESTING MARKET BY MYOGENIC DISORDER DIAGNOSIS 2012-2022 ($ BILLION) 28
TABLE 29 GLOBAL DNA TESTING MARKET BY CLINICAL DIAGNOSIS CONFIRMATION 2012-2022 ($ BILLION) 28
TABLE 30 GLOBAL DNA TESTING MARKET BY PRENATAL DIAGNOSIS2012-2022 ($ BILLION) 28
TABLE 31 GLOBAL DNA TESTING MARKET BY PRE-IMPLANTATION DIAGNOSIS2012-2022 ($ BILLION) 28
TABLE 32 GLOBAL DNA TESTING MARKET BY OTHERS 2012-2022 ($ BILLION) 28
TABLE 33 GLOBAL DNA TESTING MARKET BY END USERS 2012-2022 ($ BILLION) 28
TABLE 34 GLOBAL DNA TESTING MARKET BY POINT OF CARE 2012-2022 ($ BILLION) 28
TABLE 35 GLOBAL DNA TESTING MARKET BY CENTRAL LABORATORIES 2012-2022 ($ BILLION) 28
TABLE 36 GLOBAL DNA TESTING MARKET BY SELF TESTING OTC 2012-2022 ($ BILLION) 28
TABLE 37 NORTH AMERICA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 28
TABLE 38 NORTH AMERICA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 28
TABLE 39 NORTH AMERICA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 40 U.S. GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 41 U.S. GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 42 CANADA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 43 CANADA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 –2022 ($ BILLION) 28
TABLE 44 CANADA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 45 EUROPE GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 46 EUROPE GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 29
TABLE 47 EUROPE GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 48 GERMANY GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 49 GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 50 UK GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 51 UK GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 52 ASIA PACIFIC GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 53 ASIA PACIFIC GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 29
TABLE 54 ASIA PACIFIC GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 55 CHINA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 56 CHINA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 57 INDIA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 58 INDIA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 59 JAPAN GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 60 JAPAN GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 61 MIDDLE EAST & AFRICA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 62 MIDDLE EAST & AFRICA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 63 CENTRAL & SOUTH AMERICA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 64 CENTRAL & SOUTH AMERICA GLOBAL DNA TESTING MARKETESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30

FIGURE 1 MARKET SHARE BY REGIONS 30
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 13 CENTRAL & SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)